Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials

Journal:
The Lancet Oncology
Published:
DOI:
10.1016/s1470-2045(25)00546-7
Affiliations:
31
Authors:
32
Go to article
Institutions Authors Share
German Breast Group GmbH (GBG), Germany
3.000000
 0.09
University of Milano-Bicocca (UNIMIB), Italy
3.000000
 0.09
Humanitas Gavazzeni, Italy
2.500000
 0.08
University Hospital Frankfurt, GU, Germany
2.000000
 0.06
National Center for Tumor Diseases (NCT) Heidelberg, Germany
1.000000
 0.03
University Medical Centre Mannheim (UMM) at Medical Faculty Mannheim, Uni Heidelberg, Germany
1.000000
 0.03
IRCCS European Institute of Oncology (IEO), Italy
1.000000
 0.03
Charité - University Medicine Berlin, Germany
1.000000
 0.03
University Medical Center Hamburg-Eppendorf (UKE), UHH, Germany
1.000000
 0.03
University Hospital Aachen (UKA), RWTH Aachen, Germany
1.000000
 0.03
Helios Clinic Berlin-Buch, Germany
1.000000
 0.03
TU Dresden, Germany
1.000000
 0.03
Kantonsspital St. Gallen, Switzerland
1.000000
 0.03
University Hospital Gießen and Marburg GmbH (UKGM), Germany
1.000000
 0.03
Jerusalem Hospital Hamburg, Germany
1.000000
 0.03
University of Cologne (UoC), Germany
1.000000
 0.03
University Hospital Tübingen (UKT), Uni Tübingen, Germany
1.000000
 0.03
University Hospital of Erlangen, FAU, Germany
1.000000
 0.03
MVZ Onko Medical GmbH Hannover, Germany
1.000000
 0.03
Kliniken Essen-Mitte, Germany
1.000000
 0.03
University Hospital Duesseldorf (UKD), Germany
1.000000
 0.03
Red Cross Hospital Munich gGmbH, Germany
1.000000
 0.03
University Medical Center Schleswig-Holstein (UKSH), Germany
1.000000
 0.03
Humanitas University, Italy
0.500000
 0.02
Witten/Herdecke University (UW/H), Germany
0.500000
 0.02
Helios Universitätsklinikum Wuppertal, Germany
0.500000
 0.02
Dana-Farber Cancer Institute (DFCI), United States of America (USA)
0.500000
 0.02
Frontier Science Foundation, United States of America (USA)
0.500000
 0.02
Interested in Oncology and Carcinogenesis?